All Cosmos Bio-Tech Holding Corp (4148) — Capital Reinvestment Ratio

Latest as of March 2026: 0.05x

All Cosmos Bio-Tech Holding Corp (4148) has a Capital Reinvestment Ratio of 0.05x as of March 2026, meaning it reinvests 0% of its operating cash flow (NT$195.74 Million) in capital expenditures (NT$9.10 Million). Check All Cosmos Bio-Tech Holding Corp (4148) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.05x
Capex / Operating Cash Flow

Operating Cash Flow

NT$195.74 Million
TWD

Capital Expenditures

NT$9.10 Million
TWD

Data as of

Mar 2026
Most recent filing

All Cosmos Bio-Tech Holding Corp Capital Reinvestment Ratio (2010–2025)

This chart tracks All Cosmos Bio-Tech Holding Corp's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see All Cosmos Bio-Tech Holding Corp operating cash flow efficiency.

Annual Capital Reinvestment Ratio for All Cosmos Bio-Tech Holding Corp (2010–2025)

Year-by-year Capital Reinvestment Ratio for All Cosmos Bio-Tech Holding Corp from 2010 to 2025. See 4148 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (TWD) Capital Expenditures YoY Change
2025 0.17x NT$251.93 Million NT$42.85 Million ▼ -93.5%
2024 2.63x NT$54.19 Million NT$142.25 Million ▲ +1440.9%
2023 0.17x NT$959.24 Million NT$163.42 Million ▼ -87.7%
2022 1.39x NT$43.84 Million NT$60.86 Million ▲ +3028.3%
2019 0.04x NT$883.56 Million NT$39.21 Million ▼ -74.1%
2017 0.17x NT$176.12 Million NT$30.19 Million ▲ +612.7%
2016 0.02x NT$507.38 Million NT$12.20 Million ▼ -94.3%
2015 0.42x NT$145.77 Million NT$61.10 Million ▼ -56.9%
2014 0.97x NT$97.03 Million NT$94.30 Million ▼ -71.0%
2013 3.35x NT$41.58 Million NT$139.36 Million ▲ +68.3%
2012 1.99x NT$194.85 Million NT$388.07 Million ▲ +79.0%
2011 1.11x NT$138.05 Million NT$153.59 Million ▲ +192.2%
2010 0.38x NT$88.13 Million NT$33.55 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow